Faculty

Andy Stergachis

Adjunct Professor, Epidemiology
Professor, Pharmacy
Professor, Global Health
Adjunct Professor, Health Metrics Sciences
Associate Dean, School of Pharmacy

206-221-0703

Education

PhD Pharmacy, University of Minnesota, 1979
MS Pharmacy, University of Minnesota, 1976
BPharm Pharmacy, Washington State University, 1975

Contact

206-221-0703

Office H-362B, Health Sciences Building
Box 357631
WA

Research Interests

Dr. Stergachis' research focus is pharmacoepidemiology, global drugs and vaccine safety, pharmaceutical outcomes research, and public health systems research. He directed a pharmacovigilance pregnancy registry study on the safety of first trimester antimalarials conducted in three sub-Saharan African countries. He is one of very few pharmacists ever elected to the National Academy of Medicine. His research has been supported, in part, by the Bill and Melinda Gates Foundation, USAID, the Barr Foundation, the Partnership for Quality Medical Donations, and USP. He is a Fellow of the International Society for Pharmacoepidemiology, Chair of the Expert Panel to Review Surveillance and Screening Technologies for the Quality Assurance of Medicines for United States Pharmacopeia, Chair of the Low-dose Primaquine Safety Study Group for the WorldWide Antimalarial Resistance Network and member of the Access and Product Management Advisory Committee for Medicines for Malaria Venture. He has conducted pharmacovigilance trainings and related pharmaceutical systems strengthening activities in numerous low- and middle-income countries (e.g., Namibia, Vietnam, Rwanda, Ethiopia, Zimbabwe, China, India, Kenya, Bangladesh, Eritrea, Philippines, Uganda, and Ukraine). Through his affiliation with the Northwest Center for Public Health Practice, he also works on workforce development and research in emergency preparedness with the public health community.

Recent Publications (PubMed)

Maternal and perinatal health research during emerging and ongoing epidemic threats: a landscape analysis and expert consultation.
(2024 Mar 7)
BMJ Glob Health 9(3):
Bonet M, Babinska M, Buekens P, Goudar SS, Kampmann B, Knight M, Meaney-Delman D, Lamprianou S, Rivas FM, Stergachis A, Toscano CM, Bhatia J, Chamberlain S, Chaudhry U, Mills J, Serazin E, Short H, Steene A, Wahlen M, Oladapo OT

Safe in pregnancy: A global living systematic review and meta-analysis of COVID-19 vaccines in pregnancy.
(2024 Mar 7)
Vaccine 42(7): 1414-1416
Buekens P, Berrueta M, Ciapponi A, Bardach A, Mazzoni A, Rodriguez-Cairoli F, Gottlieb SL, Kampmann B, Parker EPK, Xiong X, Zaraa S, Stergachis A

Combining legal epidemiology and implementation science to improve global access to medicines: challenges and opportunities.
(2023)
Front Health Serv 3(): 1291183
Lane J, Stergachis A

A systematic scoping review of medicine availability and affordability in Africa.
(2024 Jan 17)
BMC Health Serv Res 24(1): 91
Lane J, Nakambale H, Kadakia A, Dambisya Y, Stergachis A, Odoch WD

Using design thinking to strengthen the community pharmacist's role in epilepsy care.
(2024 Jan)
Epilepsy Behav 150(): 109542
Zaraa S, Steve White H, Stergachis A, Novotny EJ Jr, Protos C, Simic G, Bacci JL

Show complete publication list